Warrants (Details) - Schedule of Outstanding and Exercisable Warrants - Warrant [Member] |
9 Months Ended |
|---|---|
|
Sep. 30, 2024
$ / shares
shares
| |
| Schedule of Outstanding and Exercisable Warrants [Line Items] | |
| Warrants Outstanding, Number of Shares | shares | 3,016,635 |
| Warrants Outstanding, Weighted Average Remaining Contractual life (in years) | 1 year 3 months 29 days |
| Warrants Outstanding, Weighted Average Exercise Price | $ / shares | $ 6.6907 |
| Warrants Exercisable, Number of Shares | shares | 3,016,635 |
| Warrants Exercisable, Weighted Average Exercise Price | $ / shares | $ 6.6907 |
| X | ||||||||||
- Definition Warrants exercisable, number of shares. No definition available.
|
| X | ||||||||||
- Definition Warrants exercisable, weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Warrants outstanding, weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|